Olema, Novartis ink another agreement, this time for a late-stage breast cancer trial

Ole­ma On­col­o­gy is again team­ing up with No­var­tis, with the com­pa­nies part­ner­ing on a new clin­i­cal tri­al col­lab­o­ra­tion and sup­ply agree­ment for an in­ves­ti­ga­tion­al breast …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.